18. Das, S.S., Moitra, I., Das, S., Singh, N., Verma, P.R.P., Singh, S.K. (2022). Conventional to Nanoscale-Based Carrier Systems in the Management of Ovarian Cancer. In: Rahman, M., H Almalki, W., Alrobaian, M., Beg, S., Alharbi, K.S. (eds) Hormone Related Cancer Mechanistic and Nanomedicines. Springer, Singapore. https://doi.org/10.1007/978-981-19-5558-7_5
17. Tambe, S., Das, S.S., Singh, N., Verma, P.R.P., Amin, P., Singh, S.K. (2022). Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer. In: Rahman, M., H Almalki, W., Alrobaian, M., Beg, S., Alharbi, K.S. (eds) Hormone Related Cancer Mechanistic and Nanomedicines. Springer, Singapore. https://doi.org/10.1007/978-981-19-5558-7_11
16 Das, S.S., Dubey, A.K., Singh, N., Verma, P.R.P., Singh, S.K., Singh, S.K. (2022). Pancreatic Cancer Treatment by Using Theragnostic Nanoparticles. In: Rahman, M., H Almalki, W., Alrobaian, M., Beg, S., Alharbi, K.S. (eds) Hormone Related Cancer Mechanistic and Nanomedicines. Springer, Singapore. https://doi.org/10.1007/978-981-19-5558-7_8
15 Das S.S., Moitra I., Singh S.K., Verma P.R.P., Swain S. (2022) DNA vaccines for cancer treatment: challenges and promises. In: Rahman M., Beg S., Almalki W.H., Alhakam N.A., Choudhry H. (Eds.) Nanotherapeutics in Cancer Vaccination and Challenges (pp. 259-278) Elsevier Academic Press, San Diego, CA. doi:10.1016/B978-0-12-823686-4.00017-3
14 Dubey A.K., Das S.S., Hosseinpour M., Verma P.R.P., Singh S.K., Singh S.K. (2022) mRNA-based nanovaccines as newer treatment modalities in cancer. In: Rahman M., Beg S., Almalki W.H., Alhakam N.A., Choudhry H. (Eds.) Nanotherapeutics in Cancer Vaccination and Challenges (pp. 279-293) Elsevier Academic Press, San Diego, CA. doi:10.1016/B978-0-12-823686-4.00006-9
13 Das S.S., Dubey A.K., Moitra I., Verma P.R.P., Singh S.K., Singh S.K. (2022) Therapeutic peptides in anticancer therapy. In: Rahman M., Beg S., Almalki W.H., Alhakam N.A., Choudhry H. (Eds.) Nanotherapeutics in Cancer Vaccination and Challenges (pp. 413-426) Elsevier Academic Press, San Diego, CA. doi:10.1016/B978-0-12-823686-4.00012-4
12 Das S.S., Dubey A.K., Verma P.R.P., Singh S.K., Singh S.K. (2022) Inorganic nanoconjugates for cancer theragnosis. In: Rahman M., Beg S., Almalki W.H., Alhakam N.A., Choudhry H. (Eds.) Nanotherapeutics in Cancer Vaccination and Challenges (pp. 427-445) Elsevier Academic Press, San Diego, CA. doi:10.1016/B978-0-12-823686-4.00003-3
11 Das S.S., Kar S., Singh S.K., Hussain A., Verma P.R.P., Beg S. (2022) Carboxymethyl chitosan in advanced drug delivery applications. In: Hasnain M.S., Beg S., Nayak A.K. (Eds.) Chitosan In Drug Delivery (pp. 323-360). Elsevier Academic Press, San Diego, CA. doi:10.1016/B978-0-12-819336-5.00006-6.
10 Das S.S., Kar S., Singh S.K., Verma P.R.P., Hussain A., Beg S. (2022) Chitosan-based systems for oral drug delivery applications. In: Hasnain M.S., Beg S., Nayak A.K. (Eds.) Chitosan In Drug Delivery (pp. 23-53). Elsevier Academic Press, San Diego, CA. doi:10.1016/B978-0-12-819336-5.00009-1.
9 Das S.S., Bharadwaj P., Singh S.K., Verma P.R.P., Beg S.(2022) In situ gelling systems of chitosan for potential drug delivery applications. In: Hasnain M.S., Beg S., Nayak A.K. (Eds.) Chitosan In Drug Delivery (pp. 195-224). Elsevier Academic Press, San Diego, CA. doi: 10.1016/B978-0-12-819336-5.00010-8.
8 Das, S. S., Verma, P. R. P., Singh, S. K., Singh, N., & Singh, S. K. (2021). Analytical quality by design for size-exclusion chromatography. In S. Beg, M. Rahman, M. S. Hasnain, & W. H. Almalki (Eds.), Handbook of Analytical Quality by Design (pp. 71–85). Academia Press, Elsevier. doi:10.1016/C2019-0-01419-7.
7 Das, S. S., Verma, P. R. P., & Singh, S. K. (2021). Phytoconstituent-Centered Byproducts and Nanomedicines as Leishmanicidal Scavengers. In M. Rahman, S. Beg, M. A. Zamzami, H. Choudhry, A. Ahmad, & K. S. Alharbi (Eds.), Biomarkers as Targeted Herbal Drug Discovery: A Pharmacological Approach to Nanomedicines (First ed., pp.101–132). Apple Academic Press, CRC Press-Taylor & Francis Group.
6 Das S.S., Verma P.R.P., Singh S.K. (2020) Quercetin-Loaded Nanomedicine as Nutritional Application. In: Rahman M., Beg S., Kumar V., Ahmad F. (eds) Nanomedicine for Bioactives (pp:259-301). Springer Nature, Singapore. doi:10.1007/978-981-15-1664-1_9.
5 Das S.S., Verma P.R.P., Kar S., Singh S.K. (2020) Quercetin-Loaded Nanomedicine as Oncotherapy. In: Rahman M., Beg S., Kumar V., Ahmad F. (eds) Nanomedicine for Bioactives (pp:155-183). Springer Nature, Singapore. doi:10.1007/978-981-15-1664-1_5.
4 Das S.S., Singh A., Kar S., Ghosh R., Pal M., Fatima M., Singh N., Singh S.K. (2019) Application of QbD Framework for Development of Self-Emulsifying Drug Delivery Systems. In: Beg S., Hasnain M.S. (Eds.) Pharmaceutical Quality by Design: Principles and Applications (pp. 297-350). Elsevier Academic Press, San Diego, CA. doi: 10.1016/B978-0-12-815799-2.00015-0.
3 Jayachandran Venkatesan, Sukumaran Anil, Sandeep Kumar Singh and Se-Kwon Kim (2018). Recent Advances of Alginate Biomaterials in Tissue Engineering (Chapter 9). In: Marine Polysaccharides: Advances and Multifaceted Applications. Eds: Shakeel Ahmed and Aisverya Soundararajan. pp. 207-233
2 Jayachandran Venkatesan, Sukumaran Anil, Sandeep Kumar Singh, Se-Kwon Kim (2017). Preparation and Applications of Alginate Nanoparticles (Chapter 13). In: Seaweed Polysaccharides (First Edition). Eds: Jayachandran Venkatesan, Sukumaran Anil and Se-Kwon Kim. pp. 249-266. USA, Elsevier
1 Sandeep Kumar Singh (2015). Regulatory requirement for product approvals, (Chapter 3),In: Drug Regulatory Affairs. CBS Publishers and Distributors. First edition, 2015, pp 61-86.